Dec 06, 01
|
| 08:37 ET |
NMT Medical Receives PMA Approval for CardioSEAL(R) Cardiac Septal Repair Implant
|
|
Nov 05, 01
|
| 16:05 ET |
NMT Medical Announces Sale of Vena Cava Filter Assets
|
|
Nov 01, 01
|
| 07:31 ET |
NMT Medical, Inc. Reports Third Quarter 2001 Net Income
|
|
Oct 26, 01
|
| 10:21 ET |
NMT Medical Schedules Conference Call to Discuss Third Quarter 2001 Financial Results
|
|
Oct 19, 01
|
| 11:05 ET |
NMT Medical Announces Agreement to Sell Vena Cava Filter Assets
|
|
Sep 12, 01
|
| 10:33 ET |
FDA Panel Recommends Approval of NMT Medical's CardioSEAL(R) PMA
|
|
Sep 06, 01
|
| 13:00 ET |
FDA Panel to Review NMT Medical's CardioSEAL(R) PMA
|
|
Aug 08, 01
|
| 15:00 ET |
NMT Medical, Inc. Reports Second Quarter 2001 Net Income
|
|
Aug 01, 01
|
| 10:26 ET |
NMT Medical Schedules Conference Call to Discuss Second Quarter 2001 Financial Results
|
|
Jun 08, 01
|
| 13:01 ET |
NMT Medical Announces Results of its 2001 Annual Meeting
|
|
May 04, 01
|
| 15:59 ET |
NMT Medical, Inc. Reports First Quarter 2001 Net Income
|
|
May 02, 01
|
| 15:22 ET |
NMT Medical Schedules Conference Call to Discuss First Quarter 2001 Financial Results
|
|
Apr 19, 01
|
| 15:13 ET |
NMT Medical Announces Favorable Nasdaq National Market Continued Listing Determination
|
|
Apr 17, 01
|
| 15:30 ET |
NMT Medical Announces 2001 Annual Meeting of Stockholders
|
|
Mar 26, 01
|
| 16:40 ET |
NMT Medical, Inc. Reports Fourth Quarter 2000 Net Income
|
|
Mar 21, 01
|
| 12:20 ET |
NMT Medical Schedules Conference Call to Discuss Fourth Quarter and Year 2000 Financial Results
|
|
Mar 19, 01
|
| 08:28 ET |
NMT Medical Names Richard E. Davis as Vice President and Chief Financial Officer
|
|
Feb 06, 01
|
| 08:33 ET |
NMT Medical Announces Changes in Its Board of Directors
|
|
Feb 02, 01
|
| 16:36 ET |
NMT Medical Announces Receipt of Nasdaq Letter Regarding Potential Delisting
|
|
Nov 16, 00
|
| 17:00 ET |
NMT Medical Names Anne Kulis as Vice President of Regulatory Affairs
|
|
Nov 14, 00
|
| 16:31 ET |
NMT Medical Announces Third Quarter Results and Changes in Its Board of Directors
|
|
Sep 25, 00
|
| 11:44 ET |
NMT Medical Names John E. Ahern as President and Chief Executive Officer
|
|
Aug 21, 00
|
| 19:45 ET |
NMT Medical Announces Second Quarter Results
|
|
Aug 16, 00
|
| 17:52 ET |
NMT Medical Files for Arbitration to Determine Rights To its Recovery Filter(TM)
|
|
Aug 01, 00
|
| 12:06 ET |
NMT Medical Announces Resignation of William J. Knight
|
|
Jul 18, 00
|
| 17:16 ET |
NMT Medical Streamlines its Interim Management Team
|
|
Jul 12, 00
|
| 17:29 ET |
NMT Medical Expects Record Second Quarter Sales for its CardioSEAL Septal Occluder
|
|
Jul 07, 00
|
| 14:34 ET |
NMT Medical Announces 2000 Annual Meeting of Stockholders
|
|
May 10, 00
|
| 19:20 ET |
NMT Medical Announces First Quarter 2000 Financial Results
|
|
Apr 13, 00
|
| 19:49 ET |
NMT Medical Announces 1999 Year End Results
|
|
Apr 10, 00
|
| 10:15 ET |
NMT Medical Names C. Leonard Gordon Acting Chief Executive Officer
|
|
Apr 05, 00
|
| 15:11 ET |
NMT Medical, Inc. Announces Closing of Partial Sale of Its Neurosciences Products to Integra Lifesciences Holding Corporation
|
|
Mar 21, 00
|
| 08:09 ET |
NMT Medical, Inc. Announces Partial Sale of Its Neurosciences Business To Integra LifeSciences Holding Corporation
|
|
Feb 16, 00
|
| 11:32 ET |
NMT Medical, Inc. Begins Commercial Introduction of the CardioSEAL(R) Septal Occluder to Treat Patients With PFOs Under Humanitarian Use Designation From The FDA
|
|
Feb 02, 00
|
| 10:40 ET |
NMT Medical Receives FDA Approval for Its CardioSEAL(R) Septal Occluder For The Treatment of Patent Foramen Ovale Under Humanitarian Use Designation
|
|
Dec 20, 99
|
| 08:30 ET |
NMT Medical Provides Progress Report on the U.S. Commercialization of The CardioSEAL(R) Septal Occluder Under Humanitarian Use Designation
|
|
Nov 15, 99
|
| 17:00 ET |
NMT Medical Announces Third Quarter and Nine Month 1999 Results
|
|
Nov 04, 99
|
| 16:24 ET |
NMT Medical Provides Further Update on the U.S. Commercialization of the Cardioseal(R) Septal Occluder Under Humanitarian Use Designation
|
|
Oct 22, 99
|
| 16:45 ET |
NMT Medical Announces Update on the U.S. Commercialization Of The HDE CardioSEAL(R)
|
|
Sep 28, 99
|
| 11:04 ET |
NMT Medical Receives Second Approval from the FDA for the CardioSEAL(R) Septal Occluder Under Humanitarian Use Designation
|
|
Sep 20, 99
|
| 06:30 ET |
NMT Medical Receives CE Mark Approval for its Removable Vena Cava Filter
|
|
Sep 13, 99
|
| 18:21 ET |
NMT Medical Closes $10 Million Senior Debt Facility With Brown Brothers Harriman & Co.
|
|
Sep 09, 99
|
| 08:30 ET |
NMT Medical Receives FDA Approval for the CardioSEAL(R) Septal Occluder Under Humanitarian Use Designation
|
|
Aug 11, 99
|
| 19:22 ET |
NMT Medical Announces Second Quarter and Six Month 1999 Results
|
|
Jun 03, 99
|
| 12:30 ET |
Nitinol Medical Technologies Announces Shareholder Approval of Name Change to NMT Medical, Inc.
|
|
May 27, 99
|
| 17:36 ET |
NMT Medical Adopts Stockholder Rights Plan
|
|
May 25, 99
|
| 16:19 ET |
NMT Medical's CardioSEAL Septal Occluder With STARFlex Featured in Live Cases At International Symposium in Paris, France
|
|
May 12, 99
|
| 12:31 ET |
NMT Medical Announces First Quarter 1999 Results
|
|
Apr 07, 99
|
| 10:33 ET |
Nitinol Medical Technologies (d/b/a NMT Medical) Affiliate, Image Technologies, Receives Cash Infusion
|
|
Mar 24, 99
|
| 18:33 ET |
NMT Medical Announces 1998 Fourth Quarter and Year End Results
|
|
Mar 22, 99
|
| 09:54 ET |
NMT Medical Files Patent Infringement Suit Against AGA Medical Corp.
|
|
Mar 03, 99
|
| 14:52 ET |
Nitinol Medical Technologies ('DBA NMT Medical') Receives CE Mark Approval For The Spetzler Titanium Aneurysm Clip
|
|
Feb 23, 99
|
| 08:31 ET |
Nitinol Medical Technologies Completes Enrollment for CardioSEAL(TM) Atrial Septal Defect (ASD) Trial
|
|
Jan 19, 99
|
| 09:16 ET |
Nitinol's Affiliate, Image Technologies, Receives FDA 510K Approval For Endoscopic Digital Imaging System
|
|
Jan 06, 99
|
| 10:17 ET |
Nitinol Medical Technologies Announces Agreement With CS Fluids
|
|
Nov 04, 98
|
| 18:43 ET |
Nitinol Medical Technologies Announces Third Quarter And Nine Month 1998 Results
|
|
Oct 01, 98
|
| 08:14 ET |
Nitinol Medical Technologies, Inc. Today Announced the First Human Implants of Its New CardioSEAL Occluder with STARflex Centering System
|
|
Aug 05, 98
|
| 17:12 ET |
Nitinol Medical Technologies Announces Second Quarter and Six Month 1998 Results
|
|
Jul 27, 98
|
| 17:17 ET |
Nitinol Medical Technologies Establishes International Registry to Collect Data On Clinical Use of its CardioSEAL Septal Occluder in PFO Patients
|
|
Mar 16, 98
|
| 16:30 ET |
Nitinol Medical Technologies Announces Fourth Quarter And Full Year 1997 Results
|
|
Mar 11, 98
|
| 15:04 ET |
Nitinol Medical Technologies Receives FDA Approval for Investigational Device Exemption to Conduct a Multi-Center Clinical Trial of the CardioSEAL(R) Septal Occluder for Closure of Patent Foramen Ovale
|
|
Jan 28, 98
|
| 10:00 ET |
Nitinol Medical Technologies Announces Fourth Quarter and Full Year 1997 Unaudited Results
|
|
Dec 09, 97
|
| 16:30 ET |
Nitinol Medical Technologies Receives CE Mark Approval for the Simon Nitinol Vena Cava Filter
|
|
Nov 13, 97
|
| 16:15 ET |
Nitinol Medical Technologies Announces CardioSEAL(TM) Clinical Results At American Heart Association Annual Meeting in Orlando, Florida
|
|
Nov 05, 97
|
| 16:11 ET |
Nitinol Medical Technologies Announces Third Quarter and Nine Month 1997 Results
|
|
Sep 09, 97
|
| 08:30 ET |
Nitinol Medical Technologies' Affiliate, Image Technologies, Receives Allowance Of Claims From U.S. Patent Office For Its Novel Endoscope/Camera System -- The Trocam
|
|
Sep 03, 97
|
| 16:15 ET |
Nitinol Medical Technologies Receives CE Mark Approval for the CardioSEAL(TM) Septal Occluder
|
|
Aug 06, 97
|
| 16:05 ET |
Nitinol Medical Technologies Announces 1997 Second Quarter and Six Month Results
|
|
May 29, 97
|
| 16:56 ET |
Nitinol Medical Technologies Acquires 23% Ownership of Image Technologies Corporation
|
|
May 27, 97
|
| 09:35 ET |
Nitinol Medical Technologies' Exclusive Licensee, Boston Scientific, Receives FDA Clearance for Use of the Company's Symphony Stent in Biliary Stenting
|
|
May 19, 97
|
| 15:27 ET |
Nitinol Medical Technologies Announces Preliminary Clinical Results For The CardioSEAL(TM) Septal Occluder
|
|
May 06, 97
|
| 10:19 ET |
Nitinol Medical Technologies Reports European Clinical Trial Results for Its Symphony Stent
|
|
Apr 29, 97
|
| 16:45 ET |
Nitinol Medical Technologies Announces First Quarter 1997 Results
|
|